Innovus Pharmaceuticals, Inc. has acquired Semprae Laboratories, Inc. Based in NJ, Semprae focuses on developing products for women’s sexual health and currently markets two OTC products, Zestra and Zestra Glide, which had sales of approximately $1 million in 2013.   Innovus Pharma currently has two products targeting male sexual health including EjectDelay for premature ejaculation and CIRCUMserum to help alleviate reduced sensitivity.   “This acquisition of Semprae moves Innovus Ph...